Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMECBLA)

Drug Name
3-fluorovinylglycine Drug Info
Synonyms
Fluorovinylglycine; 3-Fluorovinylglycine; FVGly; ACMC-20melc; 3-Butenoic acid, 2-amino-3-fluoro-, (S)-; AC1MIW53; 2-amino-3-fluorobut-3-enoic acid; 2-Amino-3-fluoro-3-butenoic acid; 111687-18-4; AKOS006361808; 3-Butenoic acid, 2-amino-3-fluoro-, (+-)-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
3081008
CAS Number
CAS 111581-52-3
TTD Drug ID
DMECBLA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Mycobacterium Biosynthetic alanine racemase (MycB alr)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cycloserine DMT1I52 Bacterial infection 1A00-1C4Z Approved [2]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [2]
Pyridoxamine-5'-Phosphate DMQ6POC Discovery agent N.A. Investigative [2]
Lysine Nz-Carboxylic Acid DMW1YK3 Discovery agent N.A. Investigative [2]
Propionate DM0O8N6 Discovery agent N.A. Investigative [3]
Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate DM7AW0X Discovery agent N.A. Investigative [2]
N-(5'-Phosphopyridoxyl)-D-Alanine DM3FCAI Discovery agent N.A. Investigative [2]
Pyridoxyl-Alanine-5-Phosphate DMUVCWY Discovery agent N.A. Investigative [2]
Propanoic Acid DM9TN2W Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mycobacterium Biosynthetic alanine racemase (MycB alr) TT6TMZU ALR_MYCSM Inhibitor [1]

References

1 Mechanism-based inactivation of alanine racemase by 3-halovinylglycines. J Biol Chem. 1991 Nov 15;266(32):21657-65.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers. 2003 Oct;70(2):186-200.